Alimera Sciences to Report First Quarter 2021 Financial Results on Wednesday, April 28, 2021 and Provide Corporate Update

Rhea-AI Summary

Alimera Sciences, Inc. (Nasdaq: ALIM) will report its first quarter 2021 financial results on April 28, 2021, after market close. A conference call is scheduled for April 29 at 9:00 AM ET to discuss these results and corporate developments. Participants can pre-register for the call or join via provided dial-in numbers. The call will also be accessible through a live webcast and will have a replay available for 90 days. Alimera specializes in prescription ophthalmic pharmaceuticals targeting retinal diseases.

Conference Call to be held Thursday, April 29, 2021 at 9:00am Eastern Time

ATLANTA, April 22, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera) a global pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals for the treatment of retinal diseases, announces today that it will report first quarter 2021 financial results on Wednesday, April 28, 2021 after the market close.

Management will host a conference call at 9:00 AM ET on Thursday, April 29, 2021 to review financial results and provide an update on corporate developments. Following management’s formal remarks, there will be a question and answer session.

Participants are asked to pre-register for the call.

Please note that registered participants will receive their dial-in number upon registration and will dial directly into the call without delay. Those without Internet access or who are unable to pre-register may dial in by calling 1-844-839-2190 (domestic) or 1-412-717-9583 (international). All callers should dial in approximately 10 minutes prior to the scheduled start time and ask to be joined into the Alimera Sciences call.

The conference call will also be available through a live webcast, which is also available through the company’s website.

A webcast replay of the call will be available approximately one hour after the end of the call through July 29, 2021. The webcast replay can be accessed through the above links or by calling 1-877-344-7529 (domestic) or 1-412-317-0088 (international) and using access code 10155027. The telephonic replay will be available until May 13, 2021.

About Alimera Sciences, Inc.

Alimera Sciences is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and affect millions of people in our aging populations. For more information, please visit www.alimerasciences.com.

For press inquiries:	For investor inquiries:
Jules Abraham	Scott Gordon
for Alimera Sciences	for Alimera Sciences
917-885-7378	scottg@coreir.com
julesa@coreir.com

FAQ

When will Alimera Sciences report its first quarter 2021 financial results?

Alimera Sciences will report its first quarter 2021 financial results on April 28, 2021, after market close.

What time is the Alimera Sciences conference call?

The conference call for Alimera Sciences is scheduled for April 29, 2021, at 9:00 AM ET.

How can I access the Alimera Sciences conference call?

You can access the Alimera Sciences conference call by pre-registering online or by dialing 1-844-839-2190 domestically or 1-412-717-9583 internationally.

Will there be a replay of the Alimera Sciences conference call?

Yes, a webcast replay of the call will be available approximately one hour after the call and will be accessible until July 29, 2021.